These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
104 related articles for article (PubMed ID: 16380334)
1. Adherence-blocking vaccine for amebiasis. Petri WA; Chaudhry O; Haque R; Houpt E Arch Med Res; 2006 Feb; 37(2):288-91. PubMed ID: 16380334 [TBL] [Abstract][Full Text] [Related]
2. Immunogenicity and safety of an Abhyankar MM; Xu F; Chavez D; Goodroe A; Mendoza E; Chen C; Singh DK; Varnador F; Sivananthan SJ; Kinsey R; Lykins WR; Murphy BM; Martin AR; Tomai MA; Ghosal S; Casper C; Pedersen K; Petri WA; Fox CB Hum Vaccin Immunother; 2024 Dec; 20(1):2374147. PubMed ID: 39090779 [No Abstract] [Full Text] [Related]
3. Prevention of intestinal amebiasis by vaccination with the Entamoeba histolytica Gal/GalNac lectin. Houpt E; Barroso L; Lockhart L; Wright R; Cramer C; Lyerly D; Petri WA Vaccine; 2004 Jan; 22(5-6):611-7. PubMed ID: 14741152 [TBL] [Abstract][Full Text] [Related]
4. Evaluation of the C-Terminal Fragment of Entamoeba histolytica Gal/GalNAc Lectin Intermediate Subunit as a Vaccine Candidate against Amebic Liver Abscess. Min X; Feng M; Guan Y; Man S; Fu Y; Cheng X; Tachibana H PLoS Negl Trop Dis; 2016 Jan; 10(1):e0004419. PubMed ID: 26824828 [TBL] [Abstract][Full Text] [Related]
5. Intranasal immunization with Gal-inhibitable lectin plus an adjuvant of CpG oligodeoxynucleotides protects against Entamoeba histolytica challenge. Ivory CP; Chadee K Infect Immun; 2007 Oct; 75(10):4917-22. PubMed ID: 17620349 [TBL] [Abstract][Full Text] [Related]
6. Entamoeba histolytica: from adherence to enteropathy. Ravdin JI J Infect Dis; 1989 Mar; 159(3):420-9. PubMed ID: 2536786 [TBL] [Abstract][Full Text] [Related]
7. The future for vaccine development against Entamoeba histolytica. Quach J; St-Pierre J; Chadee K Hum Vaccin Immunother; 2014; 10(6):1514-21. PubMed ID: 24504133 [TBL] [Abstract][Full Text] [Related]
8. Amoebiasis vaccine development: A snapshot on E. histolytica with emphasis on perspectives of Gal/GalNAc lectin. Singh RS; Walia AK; Kanwar JR; Kennedy JF Int J Biol Macromol; 2016 Oct; 91():258-68. PubMed ID: 27181579 [TBL] [Abstract][Full Text] [Related]
9. Adherence-inhibitory intestinal immunoglobulin a antibody response in baboons elicited by use of a synthetic intranasal lectin-based amebiasis subunit vaccine. Abd Alla MD; White GL; Rogers TB; Cary ME; Carey DW; Ravdin JI Infect Immun; 2007 Aug; 75(8):3812-22. PubMed ID: 17526742 [TBL] [Abstract][Full Text] [Related]
10. Opportunities and obstacles in developing a vaccine for Entamoeba histolytica. Miller-Sims VC; Petri WA Curr Opin Immunol; 2002 Oct; 14(5):549-52. PubMed ID: 12183151 [TBL] [Abstract][Full Text] [Related]
11. Expression, purification, and evaluation of recombinant LecA as a candidate for an amebic colitis vaccine. Barroso L; Abhyankar M; Noor Z; Read K; Pedersen K; White R; Fox C; Petri WA; Lyerly D Vaccine; 2014 Feb; 32(10):1218-24. PubMed ID: 23827311 [TBL] [Abstract][Full Text] [Related]
12. Entamoeba histolytica: Overexpression of the gal/galnac lectin, ehcp2 and ehcp5 genes in an in vivo model of amebiasis. Sánchez V; Serrano-Luna J; Ramírez-Moreno E; Tsutsumi V; Shibayama M Parasitol Int; 2016 Dec; 65(6 Pt A):665-667. PubMed ID: 27616150 [TBL] [Abstract][Full Text] [Related]
13. Nanoformulation of synergistic TLR ligands to enhance vaccination against Entamoeba histolytica. Abhyankar MM; Noor Z; Tomai MA; Elvecrog J; Fox CB; Petri WA Vaccine; 2017 Feb; 35(6):916-922. PubMed ID: 28089548 [TBL] [Abstract][Full Text] [Related]
14. Efficacy of a Gal-lectin subunit vaccine against experimental Entamoeba histolytica infection and colitis in baboons (Papio sp.). Abd Alla MD; Wolf R; White GL; Kosanke SD; Cary D; Verweij JJ; Zhang MJ; Ravdin JI Vaccine; 2012 Apr; 30(20):3068-75. PubMed ID: 22406457 [TBL] [Abstract][Full Text] [Related]
15. Identification of an epitope on the Entamoeba histolytica 170-kD lectin conferring antibody-mediated protection against invasive amebiasis. Lotter H; Zhang T; Seydel KB; Stanley SL; Tannich E J Exp Med; 1997 May; 185(10):1793-801. PubMed ID: 9151705 [TBL] [Abstract][Full Text] [Related]
16. CD4+ and CD8+ T cell- and IL-17-mediated protection against Entamoeba histolytica induced by a recombinant vaccine. Guo X; Barroso L; Lyerly DM; Petri WA; Houpt ER Vaccine; 2011 Jan; 29(4):772-7. PubMed ID: 21095257 [TBL] [Abstract][Full Text] [Related]
17. Construction and immunogenicity of a codon-optimized Entamoeba histolytica Gal-lectin-based DNA vaccine. Gaucher D; Chadee K Vaccine; 2002 Sep; 20(27-28):3244-53. PubMed ID: 12213393 [TBL] [Abstract][Full Text] [Related]
18. Host-pathogen interaction in amebiasis and progress in vaccine development. Huston CD; Petri WA Eur J Clin Microbiol Infect Dis; 1998 Sep; 17(9):601-14. PubMed ID: 9832261 [TBL] [Abstract][Full Text] [Related]
19. Progress towards development of a vaccine for amebiasis. Stanley SL Clin Microbiol Rev; 1997 Oct; 10(4):637-49. PubMed ID: 9336666 [TBL] [Abstract][Full Text] [Related]